Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Profilin 1 pseudogene 3 (PFN1P3) is one of several pseudogenes related to the functional profilin-1 (PFN1) gene in humans[7]. PFN1P3 retains sequence homology to PFN1 but does not produce a functional protein and is not known to have any direct biological activity, therapeutic relevance, or disease association. The functional PFN1 protein is a small, actin-binding protein essential for actin polymerization and involved in cellular processes such as cytoskeletal regulation, cell motility, and is implicated in diseases including neurodegeneration and cancer[1][2][4], but PFN1P3 does not share these attributes. Key points and context: - PFN1 (not PFN1P3) is a well-characterized cytoskeletal regulator and disease-associated protein[1][2][4][5]. - PFN1P3 is a pseudogene, not a therapeutic target and does not encode a protein or receptor[7]. - Pseudogenes are common in the genome and often arise from gene duplication or retrotransposition events but generally lack biological function. - Therapeutic targeting and mechanistic or biomarker information are not applicable to pseudogenes unless new research shows otherwise; no such evidence exists for PFN1P3[7]. If you intended to reference the functional actin polymerization regulator (profilin-1, PFN1) instead of the pseudogene, that target would be classified as an actin-binding protein involved in multiple cellular and disease processes[1][2][4][5], but PFN1P3 is not itself a target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Profilin 1 pseudogene 3 (PFN1P3).